BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 12073144)

  • 1. A novel mutation in PTPRC interferes with splicing and alters the structure of the human CD45 molecule.
    Jacobsen M; Hoffmann S; Cepok S; Stei S; Ziegler A; Sommer N; Hemmer B
    Immunogenetics; 2002 Jun; 54(3):158-63. PubMed ID: 12073144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A point mutation in PTPRC is associated with the development of multiple sclerosis.
    Jacobsen M; Schweer D; Ziegler A; Gaber R; Schock S; Schwinzer R; Wonigeit K; Lindert RB; Kantarci O; Schaefer-Klein J; Schipper HI; Oertel WH; Heidenreich F; Weinshenker BG; Sommer N; Hemmer B
    Nat Genet; 2000 Dec; 26(4):495-9. PubMed ID: 11101853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A point mutation in the human CD45 gene associated with defective splicing of exon A.
    Thude H; Hundrieser J; Wonigeit K; Schwinzer R
    Eur J Immunol; 1995 Jul; 25(7):2101-6. PubMed ID: 7621884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Consequences of increased CD45RA and RC isoforms for TCR signaling and peripheral T cell deficiency resulting from heterogeneous nuclear ribonucleoprotein L-like mutation.
    Wu Z; Yates AL; Hoyne GF; Goodnow CC
    J Immunol; 2010 Jul; 185(1):231-8. PubMed ID: 20505149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD45 in memory and disease.
    Tchilian EZ; Beverley PC
    Arch Immunol Ther Exp (Warsz); 2002; 50(2):85-93. PubMed ID: 12022705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PTPRC (CD45) is not associated with the development of multiple sclerosis in U.S. patients.
    Barcellos LF; Caillier S; Dragone L; Elder M; Vittinghoff E; Bucher P; Lincoln RR; Pericak-Vance M; Haines JL; Weiss A; Hauser SL; Oksenberg JR
    Nat Genet; 2001 Sep; 29(1):23-4. PubMed ID: 11528386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced frequency of a PTPRC (CD45) exon A mutation (77C-->G) in systemic sclerosis.
    Schwinzer R; Witte T; Hundrieser J; Ehlers S; Momot T; Hunzelmann N; Krieg T; Schmidt RE; Wonigeit K
    Genes Immun; 2003 Mar; 4(2):168-9. PubMed ID: 12618866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Negative regulation of CD45 by differential homodimerization of the alternatively spliced isoforms.
    Xu Z; Weiss A
    Nat Immunol; 2002 Aug; 3(8):764-71. PubMed ID: 12134145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Organization and expression of thirteen alternatively spliced exons in catfish CD45 homologs.
    Kountikov E; Wilson M; Miller N; Clem W; Bengtén E
    Dev Comp Immunol; 2004 Aug; 28(10):1023-35. PubMed ID: 15236932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No association between transmembrane protein-tyrosine phosphatase receptor type C (CD45) exon A point mutation (77C>G) and idiopathic dilated cardiomyopathy.
    Thude H; Gerlach K; Richartz B; Krack A; Brenke B; Pethig K; Figulla HR; Barz D
    Hum Immunol; 2005 Sep; 66(9):1008-12. PubMed ID: 16360841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 77 C/G mutation in the tyrosine phosphatase CD45 gene and autoimmune hepatitis: evidence for a genetic link.
    Vogel A; Strassburg CP; Manns MP
    Genes Immun; 2003 Jan; 4(1):79-81. PubMed ID: 12595907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of alternatively spliced CD45 isoforms by channel catfish clonal T and B cells is dependent on activation state of the cell and regulated by protein synthesis and degradation.
    Kountikov E; Nayak D; Wilson M; Miller NW; Bengtén E
    Dev Comp Immunol; 2010 Oct; 34(10):1109-18. PubMed ID: 20547174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD45: new jobs for an old acquaintance.
    Penninger JM; Irie-Sasaki J; Sasaki T; Oliveira-dos-Santos AJ
    Nat Immunol; 2001 May; 2(5):389-96. PubMed ID: 11323691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered CD45 expression in C77G carriers influences immune function and outcome of hepatitis C infection.
    Dawes R; Hennig B; Irving W; Petrova S; Boxall S; Ward V; Wallace D; Macallan DC; Thursz M; Hill A; Bodmer W; Beverley PC; Tchilian EZ
    J Med Genet; 2006 Aug; 43(8):678-84. PubMed ID: 16505159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of cells deficient in signaling-induced alternative splicing by use of somatic cell genetics.
    Sheives P; Lynch KW
    RNA; 2002 Dec; 8(12):1473-81. PubMed ID: 12515380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD45 isoforms in T cell signalling and development.
    McNeill L; Cassady RL; Sarkardei S; Cooper JC; Morgan G; Alexander DR
    Immunol Lett; 2004 Mar; 92(1-2):125-34. PubMed ID: 15081536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional significance of the 77C --> G polymorphism in the human CD45 gene: enhanced T-cell reactivity by variantly expressed CD45RA isoforms.
    Do HT; Baars W; Schwinzer R
    Transplant Proc; 2005; 37(1):51-2. PubMed ID: 15808544
    [No Abstract]   [Full Text] [Related]  

  • 18. Involvement of tyrosine phosphatase CD45 in apoptosis.
    Dupéré-Minier G; Desharnais P; Bernier J
    Apoptosis; 2010 Jan; 15(1):1-13. PubMed ID: 19856105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations in the tyrosine phosphatase CD45 gene in a child with severe combined immunodeficiency disease.
    Kung C; Pingel JT; Heikinheimo M; Klemola T; Varkila K; Yoo LI; Vuopala K; Poyhonen M; Uhari M; Rogers M; Speck SH; Chatila T; Thomas ML
    Nat Med; 2000 Mar; 6(3):343-5. PubMed ID: 10700239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does 77C-->G in PTPRC modify autoimmune disorders linked to the major histocompatibility locus?
    Vorechovsky I; Kralovicova J; Tchilian E; Masterman T; Zhang Z; Ferry B; Misbah S; Chapel H; Webster D; Hellgren D; Anvret M; Hillert J; Hammarstrom L; Beverley PC
    Nat Genet; 2001 Sep; 29(1):22-3. PubMed ID: 11548742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.